Jeff Chilton News Today

The US Food and Drug Administration has declined to respond to a Citizen Petition by North American Reishi Ltd (“Nammex”) on the labeling and sale of food and supplements containing fungal ingredients, citing “competing agency priorities”.

Mushroom ingredient supplier Nammex had asked FDA to clarify labeling requirements for fungi ingredients. FDA declined to take action.

A Nammex-commissioned survey of 10,000 people in the US confirms the population can easily identify a mushroom. The task may seem simple, but the act supports a greater argument by Nammex, the supplier of functional mushroom extracts, that mycelium-containing products are not mushrooms.

The Natural Products Association asks FDA to clarify mushroom labeling.

The Natural Products Association is seeking greater clarity about how fungal dietary supplements are labeled.

GO! Listen

The Natural Products Association (NPA) is seeking clarity on the labeling of fungi ingredients in dietary supplements, with a Citizen Petition requesting FDA to incorporate aspects of guidance from the American Herbal Products Association (AHPA).

Fungi Perfecti, a supplier of mycelium-based supplements, has written an open letter to address the citizen petition filed by mushroom extract company Nammex, which requested that the Food and Drug Administration act to ensure proper labeling of fungi and fungal ingredients.

/PRNewswire/ -- The makers of Host Defense® Mushrooms™, Fungi Perfecti, LLC, along with M2 Ingredients Inc., Gourmet Mushrooms, Inc., and Monterey Mushrooms...

Mushroom product manufacturer Nammex has filed a citizen petition with FDA to clarify the labeling of fungal ingredients to reduce confusion.